Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Metabolism & Toxicology|August 1, 2022
The impact of sepsis on hepatic drug metabolism in critically ill patients: a narrative reviewTim Mj Ewoldt, Alan Abdulla, Nicole Hunfeld, et al.
Journal of Critical Care|September 27, 2024
Higher doses of fluconazole are needed to ensure target attainment in critically ill adults on continuous Veno-venous hemodialysisSaskia M Coenradie, Tim J L Smeets, Richard C Kamp, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2025
Inadequate imipenem dosing in patients with decreased kidney function: a global clinical pharmacokinetic studyAnh Quan Truong, Tim J L Smeets, Jean Terrier, et al.
Blood Purification|November 5, 2023
The Clearance of Midazolam and Metabolites during Continuous Renal Replacement Therapy in Critically Ill Patients with COVID-19Tim J L Smeets, Hilde R H de Geus, Abraham J Valkenburg, et al.
Clinical Pharmacokinetics|April 10, 2022
Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19Tim J L Smeets, Abraham J Valkenburg, Mathieu van der Jagt, et al.
Therapeutic Drug Monitoring|October 17, 2021
Review of Scavenged Sampling for Sustainable Therapeutic Drug Monitoring: Do More With LessStef Schouwenburg, Robin F J van der Klip, Tim J L Smeets, et al.
Pageof 1